Lifevantage Net Profit Margin 2010-2024 | LFVN

Lifevantage net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Lifevantage Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-12-31 $0.21B $0.01B 3.77%
2024-09-30 $0.20B $0.00B 2.04%
2024-06-30 $0.20B $0.00B 1.50%
2024-03-31 $0.21B $0.00B 1.95%
2023-12-31 $0.21B $0.00B 1.42%
2023-09-30 $0.21B $0.00B 1.41%
2023-06-30 $0.21B $0.00B 1.40%
2023-03-31 $0.21B 0 0.00%
2022-12-31 $0.21B 0 0.00%
2022-09-30 $0.21B $0.00B 0.49%
2022-06-30 $0.21B $0.00B 1.46%
2022-03-31 $0.21B $0.01B 4.29%
2021-12-31 $0.21B $0.01B 4.72%
2021-09-30 $0.22B $0.01B 6.39%
2021-06-30 $0.22B $0.01B 5.88%
2021-03-31 $0.23B $0.01B 5.33%
2020-12-31 $0.23B $0.01B 5.24%
2020-09-30 $0.23B $0.01B 5.19%
2020-06-30 $0.23B $0.01B 5.17%
2020-03-31 $0.23B $0.01B 5.24%
2019-12-31 $0.23B $0.01B 5.24%
2019-09-30 $0.23B $0.01B 3.98%
2019-06-30 $0.23B $0.01B 3.54%
2019-03-31 $0.22B $0.01B 3.13%
2018-12-31 $0.22B $0.01B 3.20%
2018-09-30 $0.21B $0.01B 2.86%
2018-06-30 $0.20B $0.01B 2.96%
2018-03-31 $0.20B $0.00B 1.50%
2017-12-31 $0.19B $0.00B 0.52%
2017-09-30 $0.19B $0.00B 0.52%
2017-06-30 $0.20B $0.00B 0.50%
2017-03-31 $0.20B $0.00B 1.49%
2016-12-31 $0.21B $0.00B 1.88%
2016-09-30 $0.22B $0.01B 2.78%
2016-06-30 $0.21B $0.01B 2.91%
2016-03-31 $0.20B $0.00B 2.02%
2015-12-31 $0.19B $0.00B 2.14%
2015-09-30 $0.18B $0.00B 1.64%
2015-06-30 $0.19B $0.01B 3.68%
2015-03-31 $0.20B $0.01B 4.48%
2014-12-31 $0.21B $0.01B 4.74%
2014-09-30 $0.22B $0.01B 5.58%
2014-06-30 $0.21B $0.01B 4.67%
2014-03-31 $0.21B $0.01B 3.81%
2013-12-31 $0.21B $0.01B 4.39%
2013-09-30 $0.21B $0.01B 2.91%
2013-06-30 $0.21B $0.01B 3.37%
2013-03-31 $0.20B $0.01B 5.97%
2012-12-31 $0.19B $0.00B 2.14%
2012-09-30 $0.16B $0.01B 8.18%
2012-06-30 $0.13B $0.01B 10.32%
2012-03-31 $0.10B $-0.04B -40.63%
2011-12-31 $0.07B $-0.04B -62.86%
2011-09-30 $0.05B $-0.05B -92.31%
2011-06-30 $0.04B $-0.05B -134.21%
2011-03-31 $0.03B $-0.01B -33.33%
2010-12-31 $0.02B $-0.01B -35.00%
2010-09-30 $0.02B $-0.01B -86.67%
2010-06-30 $0.01B $-0.01B -118.18%
2010-03-31 $0.01B $-0.01B -144.44%
2009-12-31 $0.01B $-0.01B -114.29%
Sector Industry Market Cap Revenue
Medical MED/DENTAL-SUPP $0.149B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) US $88.782B 24.29
Becton Dickinson (BDX) US $48.374B 11.98
Cardinal Health (CAH) US $35.689B 18.69
Labcorp (LH) US $20.729B 16.81
Straumann Holding AG (SAUHY) CH $20.028B 0.00
Cooper (COO) US $16.458B 21.83
West Pharmaceutical Services (WST) US $15.180B 31.82
Align Technology (ALGN) US $13.165B 25.87
Henry Schein (HSIC) US $8.000B 13.78
Merit Medical Systems (MMSI) US $5.653B 27.33
DENTSPLY SIRONA (XRAY) US $2.806B 8.43
CONMED (CNMD) US $1.785B 13.35
STAAR Surgical (STAA) US $0.942B 0.00
Pro-Dex (PDEX) US $0.150B 16.38